| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 From the Laboratory of Immunology, National Eye Institute, Bethesda, Maryland; and the 2 Department of Ophthalmology, National Naval Medical Center, Bethesda, Maryland.
PURPOSE. To determine the effects of an adenovirus vector encoding vascular endothelial growth factor165 (Ad.VEGF) delivered to the subretinal space in the rat.
METHODS. An E1–deleted adenoviral vector encoding VEGF was injected into the subretinal space of Long–Evans rats. Immunohistochemistry identified VEGF expression. Histopathologic changes in the retina were determined by light and electron microscopy, immunohistochemistry, fluorescein angiography, and examination of wholemounts of choroid and retina.
RESULTS. Increased expression of VEGF only in the retinal pigment epithelium (RPE) was detected after Ad.VEGF injection. Histopathology of these eyes revealed minimal subretinal exudation at 1 week followed by the appearance of vascular structures in the subretinal space by week 2, which persisted up to 4 weeks. Shortening of photoreceptor outer segments and reduction of the outer nuclear layer were present overlying areas of neovascularization. Fluorescein angiography of animals injected with fluorescein–dextran revealed a deep complex of new vessels. Choroidal flatmounts showed new vessel formation, verified by detection of endothelial cells via immunohistochemistry, arising from the choroid with absence of change in the overlying retinal vasculature. Electron microscopy confirmed the presence of sub-RPE endothelial cells and pericytes and the loss of integrity of Bruch’s membrane, and serial sectioning demonstrated choroidal vascular growth through Bruch’s membrane.
CONCLUSIONS. These results support the hypothesis that overexpression of VEGF from RPE cells is capable of inducing choroidal neovascularization in the rat and provide a framework for further examining angiogenic processes in the RPE–choroid complex.
This article has been cited by other articles:
|
|
 |
|
  O. Tatar, K. Shinoda, E. Kaiserling, G. Pertile, C. Eckardt, A. Mohr, E. Yoeruek, P. Szurman, K. U. Bartz-Schmidt, and S. Grisanti Early Effects of Triamcinolone on Vascular Endothelial Growth Factor and Endostatin in Human Choroidal Neovascularization Arch Ophthalmol, February 1, 2008; 126(2): 193 - 199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. G. Marneros, H. She, H. Zambarakji, H. Hashizume, E. J. Connolly, I. Kim, E. S. Gragoudas, J. W. Miller, and B. R. Olsen Endogenous endostatin inhibits choroidal neovascularization FASEB J, December 1, 2007; 21(14): 3809 - 3818. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Ma, S. E. Lee, J. Guo, W. Qu, B. I. Hudson, A. M. Schmidt, and G. R. Barile RAGE Ligand Upregulation of VEGF Secretion in ARPE-19 Cells Invest. Ophthalmol. Vis. Sci., March 1, 2007; 48(3): 1355 - 1361. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Tatar, K. Shinoda, A. Adam, T. Eckert, C. Eckardt, K. Lucke, C. Deuter, K. U. Bartz-Schmidt, and S. Grisanti Effect of verteporfin photodynamic therapy on endostatin and angiogenesis in human choroidal neovascular membranes Br. J. Ophthalmol., February 1, 2007; 91(2): 166 - 173. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Campos, J. Amaral, S. P. Becerra, and R. N. Fariss A Novel Imaging Technique for Experimental Choroidal Neovascularization Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5163 - 5170. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Cashman, L. Bowman, J. Christofferson, and R. Kumar-Singh Inhibition of Choroidal Neovascularization by Adenovirus-Mediated Delivery of Short Hairpin RNAs Targeting VEGF as a Potential Therapy for AMD. Invest. Ophthalmol. Vis. Sci., August 1, 2006; 47(8): 3496 - 3504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Maminishkis, S. Chen, S. Jalickee, T. Banzon, G. Shi, F. E. Wang, T. Ehalt, J. A. Hammer, and S. S. Miller Confluent monolayers of cultured human fetal retinal pigment epithelium exhibit morphology and physiology of native tissue. Invest. Ophthalmol. Vis. Sci., August 1, 2006; 47(8): 3612 - 3624. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. K. Kim, D. Husain, N. Michaud, E. Connolly, A. M. Lane, K. Durrani, A. Hafezi-Moghadam, E. S. Gragoudas, C. A. O'Neill, J. C. Beyer, et al. Effect of Intravitreal Injection of Ranibizumab in Combination with Verteporfin PDT on Normal Primate Retina and Choroid Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 357 - 363. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Lebherz, A. M. Maguire, A. Auricchio, W. Tang, T. S. Aleman, Z. Wei, R. Grant, A. V. Cideciyan, S. G. Jacobson, J. M. Wilson, et al. Nonhuman Primate Models for Diabetic Ocular Neovascularization Using AAV2-Mediated Overexpression of Vascular Endothelial Growth Factor Diabetes, April 1, 2005; 54(4): 1141 - 1149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Marano, M. Brankov, and P. E. Rakoczy Discovery of a Novel Control Element within the 5'-Untranslated Region of the Vascular Endothelial Growth Factor: REGULATION OF EXPRESSION USING SENSE OLIGONUCLEOTIDES J. Biol. Chem., September 3, 2004; 279(36): 37808 - 37814. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Jin, Y. Chen, S. He, S. J. Ryan, and D. R. Hinton Hepatocyte Growth Factor and its Role in the Pathogenesis of Retinal Detachment Invest. Ophthalmol. Vis. Sci., January 1, 2004; 45(1): 323 - 329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Sakurai, A. Anand, B. K. Ambati, N. van Rooijen, and J. Ambati Macrophage Depletion Inhibits Experimental Choroidal Neovascularization Invest. Ophthalmol. Vis. Sci., August 1, 2003; 44(8): 3578 - 3585. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Sakurai, H. Taguchi, A. Anand, B. K. Ambati, E. S. Gragoudas, J. W. Miller, A. P. Adamis, and J. Ambati Targeted Disruption of the CD18 or ICAM-1 Gene Inhibits Choroidal Neovascularization Invest. Ophthalmol. Vis. Sci., June 1, 2003; 44(6): 2743 - 2749. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Wang, K. G. Rendahl, W. C. Manning, D. Quiroz, M. Coyne, and S. S. Miller AAV-Mediated Expression of Vascular Endothelial Growth Factor Induces Choroidal Neovascularization in Rat Invest. Ophthalmol. Vis. Sci., February 1, 2003; 44(2): 781 - 790. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Espinosa-Heidmann, I. Suner, E. P. Hernandez, W. D. Frazier, K. G. Csaky, and S. W. Cousins Age as an Independent Risk Factor for Severity of Experimental Choroidal Neovascularization Invest. Ophthalmol. Vis. Sci., May 1, 2002; 43(5): 1567 - 1573. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Isner, P. R. Vale, J. F. Symes, and D. W. Losordo Assessment of Risks Associated With Cardiovascular Gene Therapy in Human Subjects Circ. Res., August 31, 2001; 89(5): 389 - 400. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
